Ducol Organics received NSE in-principle approval for a preferential issue of 17,64,697 equity shares. This will strengthen the company's capital base and fund future growth.
Ducol Organics confirmed full utilization of its ₹31.51 Crore IPO proceeds with no deviations reported. Funds were deployed towards working capital and general corporate purposes.
Ducol Organics approved a ₹30.00 Crore preferential share swap issue to public investors. The capital raise strengthens the balance sheet through the issuance of new equity.